It's Game 7 of the Championship Series and NuVasive has the home court advantage, the anticipation is that this should be a blow out, considering that their opponent Medtronic hasn't won a game in many years. Medtronic has taken their blows. Some industry insiders began to wonder would they ever rebound, could they make the right pass, was their offense turning into an impenetrable defense. After the Michelson debacle, it seemed that Big Blue has been staggering. Even with a home crowd and the potential of some home calls, it was announced today that the NuVasive has taken it on the chin. No fellow bloggers it wasn't a Floyd Mayweather sucker punch. NuVa saw it coming.
It was announced earlier in the day, that a San Diego Jury with "laser like focus" awarded Medtronic $ 101.2 million in damages related to patent infringements by Nuvasive. Of course other publications in the industry will come to NuVa's defense claiming a wash since the jury also found that Big Blue owes NuVasive $660 thousand for infringing upon one of NuVa's patents. NuVa will now have to regroup and consider its legal option as to how to proceed with the verdict. To quote NuVa's attorney, "Nuvasive copied nothing!" A San Diego jury thought otherwise.
But some questions must be asked. How do investors continue to pour money into a company that has already lost a $60 plus million dollar trademark suit? And now, $101.2 million? It will be interesting to hear the "spin" on how "laser like" the Purple People Eaters will become as they continue their quest and journey to be a $1 Billion Dollar Company. There's no joy in Rancho Santa Fe tonight, nor do we think that anyone is drinking any Petrus. It will be interesting to see how OTW reacts and spins this verdict, considering that our boy, the oracle of the industry, loves the Big Bear. TSB wants to know how much will the markets react tomorrow to this decision?